Clinical evaluation of spermatogenic activity of processed Shilajit in oligospermia.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/20078516
Conclusion of this study
Significant decrease of semen MDA content (-18.7%) was observed. Moreover, serum testosterone (+23.5%; P < 0.001) and FSH (+9.4%; P < 0.05) levels significantly increased. HPLC chromatogram revealed inclusion of PS constituents in semen. Unaltered hepatic and renal profiles of patients indicated that PS was safe at the given dose. The present findings provide further evidence of the spermatogenic nature of Shilajit, as attributed in Ayurvedic medicine, particularly when administered as PS.
Supplements analyzed in this study
Health conditions analyzed in this study
No health conditions information for this study.
Functions related to this study
Body systems related to this study